Research shows maintaining low LDL-C levels over time reduces plaque buildup and lowers ASCVD risk by slowing atherosclerosis progression.
FDA Clears Wegovy, Other GLP-1 Drugs of Suicidality Risk for Now
GLP-1 receptor agonists likely don’t cause suicidal thoughts or actions, according to a preliminary evaluation by the FDA. The investigation was prompted after the FDA